Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study

This research successfully developed a nomogram based on the Cox regression model to predict prognosis and treatment outcomes in patients with lung adenocarcinoma and bone metastases undergoing EGFR-TKI therapy. This facilitates the avoidance of poor treatment outcomes by enabling individualized therapeutic approaches, thereby simplifying the development of the most appropriate treatment plans and ultimately improving patient prognosis.